-
EP3870213
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3870213
| EP3870213 - STABLE SEMAGLUTIDE COMPOSITIONS AND USES THEREOF [Right-click to bookmark this link] | Status | The patent has been granted Status updated on 05.05.2023 Database last updated on 27.07.2024 | |
| Former | Grant of patent is intended Status updated on 03.11.2022 | ||
| Former | Request for examination was made Status updated on 26.09.2022 | ||
| Former | Grant of patent is intended Status updated on 15.05.2022 | ||
| Former | Request for examination was made Status updated on 30.07.2021 | ||
| Former | The international publication has been made Status updated on 02.05.2020 | ||
| Former | unknown Status updated on 19.11.2019 | Most recent event Tooltip | 19.07.2024 | New entry: Reply of patent proprietor to notice(s) of opposition | Applicant(s) | For all designated states Novo Nordisk A/S Novo Allé 2880 Bagsværd / DK | [2021/35] | Inventor(s) | 01 /
ENGELUND, Dorthe, Kot Novo Allé 2880 Bagsværd / DK | 02 /
JENSEN, Søren, Skov Novo Allé 2880 Bagsværd / DK | 03 /
LUNDQVIST, Joakim Novo Allé 2880 Bagsværd / DK | [2021/35] | Representative(s) | D Young & Co LLP 3 Noble Street London EC2V 7BQ / GB | [N/P] | Application number, filing date | 19801228.8 | 25.10.2019 | [2021/35] | WO2019EP79214 | Priority number, date | EP20180202801 | 26.10.2018 Original published format: EP 18202801 | EP20190158226 | 20.02.2019 Original published format: EP 19158226 | [2021/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020084126 | Date: | 30.04.2020 | Language: | EN | [2020/18] | Type: | A1 Application with search report | No.: | EP3870213 | Date: | 01.09.2021 | Language: | EN | The application published by WIPO in one of the EPO official languages on 30.04.2020 takes the place of the publication of the European patent application. | [2021/35] | Type: | B1 Patent specification | No.: | EP3870213 | Date: | 07.06.2023 | Language: | EN | [2023/23] | Search report(s) | International search report - published on: | EP | 30.04.2020 | Classification | IPC: | A61K38/26, A61K9/00, A61K47/18, A61K47/10, A61P3/10, A61P3/04 | [2022/22] | CPC: |
A61K9/0019 (EP,IL,KR);
A61K9/08 (IL,KR);
A61K38/26 (EP,IL,KR,US);
A61K47/02 (IL,KR);
A61K47/10 (EP,IL,KR,US);
A61K47/183 (EP,IL,US);
|
| Former IPC [2021/35] | A61K38/26, A61K9/00, A61K47/18, A61P3/10 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2021/35]
| Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | MA | 26.05.2021 | TN | 26.05.2021 | Title | German: | STABILE SEMAGLUTID-ZUSAMMENSETZUNGEN UND VERWENDUNGEN DAVON | [2022/22] | English: | STABLE SEMAGLUTIDE COMPOSITIONS AND USES THEREOF | [2021/35] | French: | COMPOSITIONS STABLES DU SÉMAGLUTIDE ET LEURS UTILISATIONS | [2022/22] |
| Former [2021/35] | STABILE SEMAGLUTID-ZUSAMMENSETZUNGEN UND DEREN VERWENDUNGEN | ||
| Former [2021/35] | COMPOSITIONS DE SÉMAGLUTIDE STABLES ET LEURS UTILISATIONS | Entry into regional phase | 26.05.2021 | National basic fee paid | 26.05.2021 | Designation fee(s) paid | 26.05.2021 | Examination fee paid | Examination procedure | 26.05.2021 | Examination requested [2021/35] | 26.05.2021 | Date on which the examining division has become responsible | 16.05.2022 | Communication of intention to grant the patent | 26.09.2022 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 04.11.2022 | Communication of intention to grant the patent | 14.03.2023 | Fee for grant paid | 14.03.2023 | Fee for publishing/printing paid | 14.03.2023 | Receipt of the translation of the claim(s) | Opposition(s) | Opponent(s) | 01
07.03.2024
08.03.2024
ADMISSIBLE Generics (U.K.) Limited Building 4, Trident Place Mosquito Way Hatfield Hertfordshire AL10 9UL / GB Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | [2024/16] |
| Former [2024/15] | |||
| Opponent(s) | 01
07.03.2024
Generics (U.K.) Limited Building 4, Trident Place Mosquito Way Hatfield Hertfordshire AL10 9UL / GB Opponent's representative Ter Meer Steinmeister & Partner Patentanwälte mbB Nymphenburger Straße 4 80335 München / DE | 20.03.2024 | Invitation to proprietor to file observations on the notice of opposition | 18.07.2024 | Reply of patent proprietor to notice(s) of opposition | Fees paid | Renewal fee | 02.11.2021 | Renewal fee patent year 03 | 31.10.2022 | Renewal fee patent year 04 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | MC | 07.06.2023 | SM | 07.06.2023 | IS | 07.10.2023 | [2024/28] |
| Former [2024/09] | SM | 07.06.2023 | |
| IS | 07.10.2023 | ||
| Former [2024/08] | SM | 07.06.2023 | Cited in | International search | [A]WO2005049061 (NOVO NORDISK AS [DK], et al); | [A]WO2016038521 (SUN PHARMACEUTICAL IND LTD [IN]); | [A]WO2017186896 (NOVO NORDISK AS [DK]); | [A]WO2018115901 (ARECOR LTD [GB]) | by applicant | WO2006097537 | Opposition | WO9924071 | WO0149314 | EP1197222 | WO03002136 | WO2006097537 | WO2012080471 | WO2013127779 | WO2013139694 | WO2020084126 |